BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6618773)

  • 1. Adverse effect of indomethacin in experimental chronic nephrosis.
    Kleinknecht C; Laouari D; Gubler MC; Gros F
    Int J Pediatr Nephrol; 1983 Jun; 4(2):83-8. PubMed ID: 6618773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ameliorative effects of dietary protein restriction in chronic aminonucleoside nephrosis.
    Diamond JR; Karnovsky MJ
    J Lab Clin Med; 1987 May; 109(5):538-44. PubMed ID: 3572200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of orosomucoid on the glomerular barrier in puromycin aminonucleoside-induced nephrosis.
    Hjalmarsson C; Lidell ME; Haraldsson B
    Nephrol Dial Transplant; 2006 May; 21(5):1223-30. PubMed ID: 16410268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
    Grond J; Weening JJ; Elema JD
    Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis.
    Zheng Y; Shirato I; Maeda A; Kobayashi N; Liao J; Shou I; Fukui M; Tomino Y
    J Nephrol; 2002; 15(1):36-41. PubMed ID: 11936424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of captopril on chronic puromycin aminonucleoside nephrosis in rats.
    Radin MJ; Wilke WL; Fettman MJ
    Res Commun Chem Pathol Pharmacol; 1986 Nov; 54(2):279-82. PubMed ID: 3538253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
    Nakayama K; Natori Y; Sato T; Kimura T; Sugiura A; Sato H; Saito T; Ito S; Natori Y
    J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a low-protein diet on expression of non-muscle type myosin heavy-chain isoforms in glomeruli of rats with puromycin aminonucleoside nephrosis.
    Koide H; Nakamura T; Kimura K; Ebihara I; Nagai R; Tomino Y
    Nephrol Dial Transplant; 1996 Sep; 11(9):1769-74. PubMed ID: 8918620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of glomerular visceral epithelial cell endocytosis during nephrosis induced by puromycin aminonucleoside.
    Schwartz MM; Sharon Z; Pauli BU; Lewis EJ
    Lab Invest; 1984 Dec; 51(6):690-6. PubMed ID: 6389977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A scanning and transmission electron microscopic comparison of puromycin aminonucleoside-induced nephrosis to hyperalbuminemia-induced proteinuria with emphasis on kidney podocyte pedicel loss.
    Andrews PM
    Lab Invest; 1977 Feb; 36(2):183-97. PubMed ID: 839733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural study on nephrin expression in experimental puromycin aminonucleoside nephrosis.
    Lee YK; Kwon T; Kim DJ; Huh W; Kim YG; Oh HY; Kawachi H
    Nephrol Dial Transplant; 2004 Dec; 19(12):2981-6. PubMed ID: 15385636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporin reduces proteinuria in rats with aminonucleoside nephrosis.
    Kokui K; Yoshikawa N; Nakamura H; Itoh H
    J Pathol; 1992 Mar; 166(3):297-301. PubMed ID: 1517884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glomerular mesangium. Analysis of the increased activity observed in experimental acute aminonucleoside nephrosis in the rat.
    Grond J; Elema JD
    Lab Invest; 1981 Nov; 45(5):400-9. PubMed ID: 7300251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of FK506 on aminonucleoside-induced nephrotic rats].
    Kawaguchi S
    Nihon Jinzo Gakkai Shi; 1992 Feb; 34(2):141-51. PubMed ID: 1375300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats.
    Kim BS; Park HC; Kang SW; Choi KH; Ha SK; Han DS; Lee HY
    Yonsei Med J; 2005 Feb; 46(1):141-8. PubMed ID: 15744817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activities of lysosomal enzymes in isolated glomeruli. Alterations in experimental nephrosis.
    Velosa JA; Shah SV; Ou SL; Abboud HE; Dousa TP
    Lab Invest; 1981 Dec; 45(6):522-6. PubMed ID: 7321525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in puromycin aminonucleoside nephrosis in two rat strains.
    Grond J; Muller EW; van Goor H; Weening JJ; Elema JD
    Kidney Int; 1988 Feb; 33(2):524-9. PubMed ID: 3361753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease of glomerular disialogangliosides in puromycin nephrosis of the rat.
    Holthöfer H; Reivinen J; Solin ML; Haltia A; Miettinen A
    Am J Pathol; 1996 Sep; 149(3):1009-15. PubMed ID: 8780404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular podocyte cell junctions in nephrotic syndrome. I. Freeze-fracture studies in rat aminonucleoside nephrosis.
    Kühn K; Sterzel RB; Reale E
    J Submicrosc Cytol; 1981 Jul; 13(3):407-12. PubMed ID: 7334544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podocyte architecture in puromycin aminonucleoside-treated rats administered tungsten or allopurinol.
    Ricardo SD; Bertram JF; Ryan GB
    Exp Nephrol; 1995; 3(5):270-9. PubMed ID: 7583048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.